Emerging Insights on the Diverse Roles of Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9) in Chronic Liver Diseases: Cholesterol Metabolism and Beyond.
Treatment-Induced Viral Cure of Hepatitis C Virus-Infected Patients Involves a Dynamic Interplay among three Important Molecular Players in Lipid Homeostasis: Circulating microRNA (miR)-24, miR-223, and Proprotein Convertase Subtilisin/Kexin Type 9.
Ebiomedicine
Hyrina, Anastasia A; Olmstead, Andrea D AD; Steven, Paul P; Krajden, Mel M; Tam, Edward E; Jean, François F
Plasma Membrane Tetraspanin CD81 Complexes with Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9) and Low Density Lipoprotein Receptor (LDLR), and Its Levels Are Reduced by PCSK9.
The Journal Of Biological Chemistry
Le, Quoc-Tuan QT; Blanchet, Matthieu M; Seidah, Nabil G NG; Labonté, Patrick P
Identification of a small peptide that inhibits PCSK9 protein binding to the low density lipoprotein receptor.
The Journal Of Biological Chemistry
Zhang, Yingnan Y; Eigenbrot, Charles C; Zhou, Lijuan L; Shia, Steven S; Li, Wei W; Quan, Clifford C; Tom, Jeffrey J; Moran, Paul P; Di Lello, Paola P; Skelton, Nicholas J NJ; Kong-Beltran, Monica M; Peterson, Andrew A; Kirchhofer, Daniel D